These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8290795)

  • 1. Salivary immunoglobulin A production in chronic bronchitis patients given an orally administered bacterial extract.
    Spiropoulos K; Lymberopoulos D; Garantziotis G; Gogos C
    Respiration; 1993; 60(6):313-8. PubMed ID: 8290795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom, on T lymphocytes, macrophages, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables.
    Emmerich B; Emslander HP; Pachmann K; Hallek M; Milatovic D; Busch R
    Respiration; 1990; 57(2):90-9. PubMed ID: 2122507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between serum and salivary IgA and oral aerobic bacterial flora in patients with chronic bronchitis].
    Misirligil Z; Saygun N; Yavuz S; Atakurt Y
    Mikrobiyol Bul; 1985 Jan; 19(1):23-8. PubMed ID: 3872401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin production in man stimulated by an orally administered bacterial lysate.
    Puigdollers JM; Serna GR; Hernandez del Rey I; Barruffet MT; Torroella JJ
    Respiration; 1980; 40(3):142-9. PubMed ID: 7003667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of analysis of immunoglobulin A levels in saliva].
    Bokor-Bratić M
    Med Pregl; 2000; 53(3-4):164-8. PubMed ID: 10965682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease.
    Li J; Zheng JP; Yuan JP; Zeng GQ; Zhong NS; Lin CY
    Chin Med J (Engl); 2004 Jun; 117(6):828-34. PubMed ID: 15198881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study.
    Cvoriscec B; Ustar M; Pardon R; Palecek I; Stipic-Markovic A; Zimic B
    Respiration; 1989; 55(3):129-35. PubMed ID: 2682862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis.
    Lusuardi M; Capelli A; Carli S; Spada EL; Spinazzi A; Donner CF
    Chest; 1993 Jun; 103(6):1783-91. PubMed ID: 8404101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of secretory immunoglobulin A in the saliva of children with recurrent and chronic respiratory tract diseases during a stay at a health resort].
    Ring B; Hein J; Seyfarth M
    Kinderarztl Prax; 1991; 59(7-8):225-30. PubMed ID: 1921174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a bacterial extract on local immunity of the lung in patients with chronic bronchitis.
    Emmerich B; Emslander HP; Milatovic D; Hallek M; Pachmann K
    Lung; 1990; 168 Suppl():726-31. PubMed ID: 2117184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
    Shimauchi H
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter double-blind study of the action of Broncho-Vaxom in chronic bronchitis].
    Keller R
    Schweiz Med Wochenschr; 1984 Jun; 114(25):934-7. PubMed ID: 6379871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of bronchovaxom in the treatment of patients with chronic obstructive bronchitis and bronchial asthma].
    Shmelev EI; Sokolova LV; Kosmiadi GA; Abramova ZP; Filippov VP; Evgushchenko GV
    Probl Tuberk; 1995; (3):37-41. PubMed ID: 7617633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The level of secretory IgA in saliva of patients with dental infections.
    Szyszkowska AM
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):528-34. PubMed ID: 16146142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effects of an immunostimulating product on recurrent infections of chronic bronchitis in the elderly.
    Debbas N; Derenne JP
    Lung; 1990; 168 Suppl():737-40. PubMed ID: 2117186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans.
    Seemann R; Hägewald SJ; Sztankay V; Drews J; Bizhang M; Kage A
    Clin Oral Investig; 2004 Dec; 8(4):233-7. PubMed ID: 15316859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary IgA concentration is influenced by the saliva collection method.
    Aufricht C; Tenner W; Salzer HR; Khoss AE; Wurst E; Herkner K
    Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):81-3. PubMed ID: 1581413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and salivary IgG and IgA response to initial preparation therapy.
    Reiff RL
    J Periodontol; 1984 May; 55(5):299-305. PubMed ID: 6588189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of specific salivary IgA responses in man after oral challenge by ribosomal immunostimulant.
    Kolopp-Sarda MN; Béné ME; Allaire JM; Perruchet AM; Faure GC
    Int J Immunopharmacol; 1997 Mar; 19(3):181-6. PubMed ID: 9306157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoglobulin A in saliva of children: age dependence and effect of respiratory tract diseases].
    Hofstötter H; Riedler J; Huber EG
    Wien Klin Wochenschr; 1996; 108(20):640-2. PubMed ID: 9005679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.